Search

Your search keyword '"GlaxoSmithKline PLC -- Intellectual property"' showing total 3 results
Start Over Descriptor "GlaxoSmithKline PLC -- Intellectual property" Publisher pjb publications
3 results on '"GlaxoSmithKline PLC -- Intellectual property"'

1. GSK faces Avandia patent challenge

Subjects
GlaxoSmithKline PLC -- Cases, GlaxoSmithKline PLC -- Intellectual property, Dr. Reddy's Laboratories Ltd. -- Cases, Dr. Reddy's Laboratories Ltd. -- Intellectual property, Teva Pharmaceutical Industries Ltd. -- Intellectual property, Teva Pharmaceutical Industries Ltd. -- Cases, Pharmaceutical industry -- Cases, Pharmaceutical industry -- Intellectual property, Company legal issue, Business, Pharmaceuticals and cosmetics industries, Avandia (Medication) -- Intellectual property, Avandia (Medication) -- Cases
Abstract

GlaxoSmithKline PLC's patent for the Avandia diabetes drug is being challenged by Dr Reddy's and by Teva Pharmaceutical. Dr Reddy's is attempting to gain 'first-filer' status for the drug.

Published
2003

2. GSK Paxil patent move could benefit Apotex

Subjects
GlaxoSmithKline PLC -- Intellectual property, Apotex Inc. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Pharmaceuticals and cosmetics industries, Paxil (Medication) -- Intellectual property
Abstract

GlaxoSmithKline PLC is requesting the US Food and Drug Administration to remove three Paxil drug patents from its Orange Book register. The patent removals could help Apotex, a generic drug maker.

Published
2003

3. US court upholds GSK's Ceftin patent

Subjects
GlaxoSmithKline PLC -- Intellectual property, Patents -- Cases, Pharmaceutical industry -- Intellectual property, Company legal issue, Patent/copyright issue, Business, Pharmaceuticals and cosmetics industries, Ceftin (Medication) -- Intellectual property
Abstract

GlaxoSmithKline PLC's (GSK) patent for its Ceftin cephalosporin drug has been upheld by a federal judge in Illinois. GSK said that the ruling will prevent Apotex from introducing a generic version until the expiration of the patents.

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results